Unimicron Technology (3037) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
5 Jun, 2026Executive summary
Net sales for Q1 2026 reached NT$37,446M, up 7.9% sequentially and 24.5% year-over-year.
Net income surged to NT$5,381M, a 37% increase quarter-over-quarter and 482% year-over-year.
Basic EPS for Q1 2026 was NT$3.28, up from NT$2.32 last quarter and NT$0.60 a year ago.
Comprehensive income for Q1 2026 totaled NT$6.56 billion, up from NT$1.72 billion in Q1 2025.
Financial highlights
Gross margin improved to 18.0% from 15.8% last quarter and 13.4% a year ago.
Operating income increased 17% quarter-over-quarter and 118% year-over-year.
Operating profit margin rose to 7% from 4% year-over-year.
Cash and cash equivalents increased to NT$60,179M as of March 31, 2026, up from NT$44,143M a year earlier.
Total assets grew to NT$266.88 billion, up from NT$234.84 billion as of March 31, 2025.
Outlook and guidance
Forward-looking statements highlight risks and uncertainties that may impact future performance.
Board resolved to issue new common shares and restricted stock to employees, pending shareholder approval.
Plans for overseas depositary receipts and further capital increases to support future development.
Latest events from Unimicron Technology
- Sales and net income rose sharply, driven by substrate and automotive growth, with higher cash reserves.3037
Q4 202513 Apr 2026 - Net sales up 12% to NT$96.55B, net income down 38%, with new bonds and HK listing planned.3037
Q3 202512 Dec 2025 - Revenue up 15% but profit and margins fell sharply amid major merger and FX risks.3037
Q2 20258 Sep 2025 - Q1 2025 revenue rose 14% year-over-year, but net income and margins declined.3037
Q1 202519 Jun 2025 - Sales up 13.8% in Q3 2024, but net income and margins declined amid expansion efforts.3037
Q3 202413 Jun 2025 - Revenue rose but profit and margins fell due to higher costs and margin pressure.3037
Q2 202413 Jun 2025 - Sales up 11%, net income down 55–58%, dividend proposed, inventory risk persists.3037
Q4 20245 Jun 2025